Latest Regulatory Framework News

Page 19 of 21
Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet the company maintains strong profitability and advances its carbon capture and storage projects alongside ambitious climate goals.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Wingara AG Limited’s shares have been suspended from ASX trading following a transaction announcement that could alter its core activities. The suspension will last until the company meets key listing rule requirements.
Ada Torres
Ada Torres
29 Apr 2025
Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Santos Limited's 2024 Annual Report reveals a 5% decline in production and a 9% drop in sales revenue, yet the company maintains strong profitability and advances its carbon capture and storage projects alongside ambitious climate targets.
Maxwell Dee
Maxwell Dee
28 Apr 2025
Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage and emissions reduction targets.
Maxwell Dee
Maxwell Dee
19 Feb 2025
Antilles Gold Limited is raising $1 million through a share and option placement to support working capital and development of its Nueva Sabana copper-gold mine in Cuba.
Maxwell Dee
Maxwell Dee
18 Feb 2025
Artemis Resources has clarified the permitting status of its Radio Hill processing plant and outlined the regulatory and operational steps required to resume processing activities, while granting Greentech Metals an exclusive option to assess copper ore feasibility.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Ionic Rare Earths Limited has signed a non-binding MOU with South Korea's DNA Link to collaborate on rare earth magnet recycling and supply, marking a strategic push into Asia and the US markets.
Maxwell Dee
Maxwell Dee
13 Feb 2025
Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.
Victor Sage
Victor Sage
12 Feb 2025
The Commonwealth Bank of Australia has released its December 2024 Basel III Pillar 3 report, reaffirming strong capital adequacy and liquidity positions despite evolving regulatory frameworks.
Victor Sage
Victor Sage
12 Feb 2025
Bryah Resources has successfully completed the first tranche of its capital raising, securing $370,542 to fund copper exploration and working capital. The company now looks ahead to shareholder approval for the next phase of its placement.
Maxwell Dee
Maxwell Dee
11 Feb 2025
Gladiator Resources has acknowledged a breach of its Securities Trading Policy following an on-market trade during a Black-Out Period, prompting a review of its compliance framework. The company reassures investors that subsequent trades were compliant and that governance standards remain a priority.
Victor Sage
Victor Sage
10 Feb 2025